FAU.de
Deutsch
Login
Home
Publications
Research Grants
Inventions & Patents
Awards
Additional Research Activities
Faculties & Institutions
Research Areas
DIAKOVERE gGmbH (Diakonische Dienste Hannover (DDH))
others
Location:
Hannover, Germany (DE)
ISNI
: -
Publications
(35)
Research Grants
(1)
Types of publications
Toggle all
Journal article
Journal article
Book chapter / Article in edited volumes
Book chapter / Article in edited volumes
Authored book
Authored book
Translation
Translation
Thesis
Thesis
Edited Volume
Edited Volume
Conference contribution
Conference contribution
Other publication type
Other publication type
Unpublished / Preprint
Unpublished / Preprint
Publication year
From
To
Abstract
Journal
Filters (inactive)
A multicentre, randomised, double-blind, phase II study to evaluate the tolerability of an induction dose escalation of everolimus in patients with metastatic breast cancer (DESIREE) (2022)
Schmidt M, Lübbe K, Decker T, Thill M, Bauer L, Müller V, Link T, et al.
Journal article
Characteristics of patients with brain metastases from human epidermal growth factor receptor 2-positive breast cancer: subanalysis of Brain Metastases in Breast Cancer Registry (2022)
Laakmann E, Witzel I, Neunhoeffer T, Park-Simon TW, Weide R, Riecke K, Polasik A, et al.
Journal article
Clinical, serological and genetic predictors of response to immunotherapy in anti-IgLON5 disease (2022)
Grueter T, Moellers FE, Tietz A, Dargvainiene J, Melzer N, Heidbreder A, Strippel C, et al.
Journal article
Induction of LabourGuideline of the DGGG, OEGGG and SGGG (S2k, AWMF Registry No. 015-088, December 2020) (2021)
Kehl S, Hösli I, Pecks U, Reif P, Schild RL, Schmidt M, Schmitz D, et al.
Journal article
Germline BRCA1/2 mutations and severe haematological toxicities in patients with breast cancer treated with neoadjuvant chemotherapy (2021)
Furlanetto J, Möbus V, Schneeweiss A, Rhiem K, Tesch H, Blohmer JU, Lübbe K, et al.
Journal article
A multicenter, randomized, double-blind, phase II study to evaluate the tolerability of an induction dose escalation of everolimus in patients with metastatic breast cancer (mBC) (DESIREE) (2021)
Loibl S, Schmidt M, Luebbe K, Decker T, Thill M, Bauer L, Mueller V, et al.
Conference contribution
Characteristics and clinical outcome of breast cancer patients with asymptomatic brain metastases (2020)
Laakmann E, Witzel I, Neunhoeffer T, Weide R, Schmidt M, Park-Simon TW, Mobus V, et al.
Conference contribution
Predicting prognosis of breast cancer patients with brain metastases in the BMBC registry - comparison of three different prognostic scores (2020)
Riecke K, Mueller , Neunhoeffer T, Weide R, Schmidt M, Park-Simon TW, Mundhenke C, et al.
Conference contribution
Influence of sonographic fetal weight estimation in (suspected) fetal macrosomia on perinatal outcome (2020)
Pretscher J, Kehl S, Stelzl P, Stumpfe F, Mayr A, Schmid M, Staerk C, et al.
Conference contribution
Survival analysis of the randomized phase III GeparOcto trial comparing neoadjuvant chemotherapy (NACT) of iddEPC versus weekly paclitaxel, liposomal doxorubicin (plus carboplatin in triplenegative breast cancer, TNBC) (PM(Cb)) for patients (pts) with highrisk early breast cancer (BC) (2020)
Schneeweiss A, Moebus V, Tesch H, Klare P, Denkert C, Kast K, Hanusch C, et al.
Conference contribution
‹
1
2
3
4
›